Since 1995, Dr. Sung (Dr. Song Jiude), founder of ESSENCE, began to study the topic of myopia control and keratosurgery, and joined the corneal shaping technology research and development team led by Dr. Day, the president of the American Academy of Corrections. In 1997, it successfully developed the world's first five-arc inversion geometric design "Fargo" lens, and obtained the safety certification of the US FDA corneal resizing lens in 2001. In 2005, Dr.Sung once again redesigned the relationship between the depth of the arc and the tear pressure between each curved arc based on the principle of interface hydraulics, developed and designed an innovative Essence system, and adopted a Paragon with high oxygen permeability and comfort. HDS100 material has created the brand Jingxi series products, which has made a qualitative leap in safety and application of corneal shaping technology and introduced it to Asia. At present, Dr. Sung is still continuing to develop biochemical materials and special optical design, hoping to develop more new technologies and products that can maintain eye and vision health with innovative thinking.

In 2011, Jingsi Keratosculectomy was launched in China. With its unique innovative mechanism of technology, processes and talents, Jingsi is committed to developing high-quality optical products suitable for Chinese patients and meet the needs of the Chinese market. At present, Jingxi's fitting medical institutions in more than 20 provinces and cities across the country are equipped with advanced instruments and equipment and front-line professional doctors. They accurately produce differentiated corneal topographic maps for the different situations of each patient's eyes and make lenses It matches the patient's eyeball level.

On October 27, 2022, Shanghai Jingshi Investment Management Co., Ltd. officially joined Lepu (Beijing) Medical Devices Co., Ltd. and became a member of Lepu Medical Group. It has been deeply involved in the ophthalmology industry and is the core of Lepu Medical's ophthalmology sector. One of the products. This cooperation will accelerate the industrial layout of Jingxi in the field of myopia prevention and control, and promote the continuous research and development and innovation of Jingxi's keratometer reshaping mirror technology. At the same time, the two parties will complement each other's advantages and develop in a coordinated manner on all lines to strengthen brand building and team building and team building. Development and promote the further expansion of Jingguan Corneal Reshaping Mirror Brand and Product in the domestic market.

As a brand of continuous innovation in myopia management among adolescents, Jingshi has always insisted on technological innovation to promote the development of enterprises, helped doctors to carry out myopia management, and insisted on exploring and striving to protect the health of vision of adolescents.